DK2054050T3 - Behandling af brusksygdomme med FGF-18 - Google Patents

Behandling af brusksygdomme med FGF-18

Info

Publication number
DK2054050T3
DK2054050T3 DK07802876.8T DK07802876T DK2054050T3 DK 2054050 T3 DK2054050 T3 DK 2054050T3 DK 07802876 T DK07802876 T DK 07802876T DK 2054050 T3 DK2054050 T3 DK 2054050T3
Authority
DK
Denmark
Prior art keywords
fgf
treatment
cartilage disease
cartilage
disease
Prior art date
Application number
DK07802876.8T
Other languages
Danish (da)
English (en)
Inventor
Christoph H Ladel
Alberto Gimona
Baur Elmar Vom
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Priority claimed from PCT/EP2007/058830 external-priority patent/WO2008023063A2/en
Application granted granted Critical
Publication of DK2054050T3 publication Critical patent/DK2054050T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK07802876.8T 2006-08-25 2007-08-24 Behandling af brusksygdomme med FGF-18 DK2054050T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06119557 2006-08-25
US84060006P 2006-08-28 2006-08-28
PCT/EP2007/058830 WO2008023063A2 (en) 2006-08-25 2007-08-24 Treatment of cartilage disorders with fgf-18

Publications (1)

Publication Number Publication Date
DK2054050T3 true DK2054050T3 (da) 2012-09-03

Family

ID=37684849

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07802876.8T DK2054050T3 (da) 2006-08-25 2007-08-24 Behandling af brusksygdomme med FGF-18

Country Status (11)

Country Link
CN (1) CN101505787B (sl)
BR (1) BRPI0715728A8 (sl)
DK (1) DK2054050T3 (sl)
ES (1) ES2392883T3 (sl)
MY (1) MY148277A (sl)
NZ (1) NZ574216A (sl)
PT (1) PT2054050E (sl)
RS (1) RS52710B (sl)
SI (1) SI2054050T1 (sl)
UA (1) UA99818C2 (sl)
ZA (1) ZA200900426B (sl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014023703A1 (en) * 2012-08-06 2014-02-13 Ares Trading S.A. Genetic markers for predicting responsiveness to fgf-18 compound
JP6495934B2 (ja) * 2014-02-20 2019-04-03 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ グラフト移植および組織工学的手順におけるｆｇｆ−１８
AU2015220785B2 (en) * 2014-02-20 2018-07-19 Merck Patent Gmbh Implant comprising FGF-18
BR112016018685A2 (pt) * 2014-02-20 2017-10-17 Merck Patent Gmbh regime de dosagem com composto de fgf-18
EP3250223A1 (en) * 2015-01-08 2017-12-06 University of Iowa Research Foundation Methods for the regeneration of articular cartilage in vivo
US11020454B2 (en) 2015-07-15 2021-06-01 Prosit Sole Biotechnology (Beijing) Co. Ltd Fusion polypeptides and methods of use
RU2745453C2 (ru) * 2015-08-13 2021-03-25 Мерк Патент Гмбх Комбинированная композиция, содержащая соединение fgf-18
CN115397844A (zh) * 2019-11-21 2022-11-25 雷姆迪亚生物公司 生长因子恢复
US11904006B2 (en) 2019-12-11 2024-02-20 University Of Iowa Research Foundation Poly(diaminosulfide) particle-based vaccine
CN117721115A (zh) * 2022-09-06 2024-03-19 深圳瑞吉生物科技有限公司 用于治疗骨关节炎的mRNA及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040136970A1 (en) * 2002-10-07 2004-07-15 Ellsworth Jeff L. Methods for administering FGF18
US20060009389A1 (en) * 2004-07-06 2006-01-12 Moore Emma E Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use
PT1828239E (pt) * 2004-12-10 2011-10-27 Zymogenetics Inc Produção de fgf18 em hospedeiros procarióticos

Also Published As

Publication number Publication date
BRPI0715728A8 (pt) 2018-04-03
BRPI0715728A2 (pt) 2013-09-17
NZ574216A (en) 2011-11-25
UA99818C2 (ru) 2012-10-10
SI2054050T1 (sl) 2012-12-31
MY148277A (en) 2013-03-29
RS52710B (en) 2013-08-30
CN101505787A (zh) 2009-08-12
CN101505787B (zh) 2013-09-04
PT2054050E (pt) 2012-09-17
ZA200900426B (en) 2010-04-28
ES2392883T3 (es) 2012-12-14

Similar Documents

Publication Publication Date Title
DK2054050T3 (da) Behandling af brusksygdomme med FGF-18
DK1986633T3 (da) Behandling af duchennes muskeldystrofi
DK2056807T3 (da) Behandling af inflammatoriske sygdomme
LTC2787345I2 (lt) Fabri ligos gydymo priemonės
PL2054050T3 (pl) Leczenie zaburzeń chrząstki z zastosowaniem FGF-18
DK2700786T3 (da) Modifikation af overførselspassage
DK2222272T3 (da) Behandling af luftvejssygdom
DK2084174T3 (da) Fremstilling af ribofuranosylpyrimidinnukleotider
DK2982696T3 (da) Behandling af akut lymfoblastær leukæmi
DK1890684T3 (da) Behandling af søvn/vågenhedsforstyrrelser
ATE528296T1 (de) Polymorphe form von 4-ä3-(4- cyclopropancarbonylpiperazin-1-carbonyl)-4- fluorbenzylü-2h-phthalazin-1-on
DK1874781T3 (da) Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme
BRPI0811265A2 (pt) Tratamento de sinucleinopatias
DK2219469T3 (da) Modificering af enzymatisk disponerede proteiner
DK2091673T3 (da) Elektromagnetisk behandling af kontaminerede materialer
BRPI0815551A2 (pt) Tratamento através de hucbc de doença beta-amiloide
DK2034830T3 (da) Anti-vla-1-antistof til behandling af slagtilfælde
DK1962869T3 (da) Behandling af luftvejssygdomme
DK1981506T6 (da) Langtidsbehandling af hiv-infektion med tcm278
DK2087176T3 (da) Rengøring af kunstige græstørv
DK2056858T3 (da) Behandling af lungesygdomstilstande
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
DK2175849T3 (da) Behandling af melanomer
DK2222289T3 (da) Behandling af oral pharyngeal dysphagi
DK2190451T3 (da) Behandling af atherosklerose